| The Short-Term Efficacy of Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema. |
|
Seok Joon Kong, Ji Wook Yang, Dong Hyun Jee |
|
Department of Ophthalmology and Visual Science, The Catholic University of Korea School of Medicine, Suwon, Korea. Dhjee73@nate.com |
| 당뇨황반부종에서의 유리체강내 라니비주맙 주입술의 단기효과 |
|
공석준ㆍ양지욱ㆍ지동현 |
|
Department of Ophthalmology and Visual Science, The Catholic University of Korea School of Medicine, Suwon, Korea |
|
|
| Abstract |
PURPOSE
To evaluate the short-term effect of an intravitreal injection of ranibizumab in the treatment of diabetic macular edema. METHODS: Eighteen eyes of 18 patients who underwent intravitreal ranibizumab injection for the treatment of diabetic macular edema between March 1 and November 30, 2009 were retrospectively evaluated. Complete ophthalmic examinations including best corrected visual acuity and optical coherence tomography (OCT) were performed at baseline and follow-up visits at one and three months. RESULTS: The mean Visual Acuity Improved From Logmar 0.74 +/- 0.45 At Baseline To Logmar 0.44 +/- 0.26 At One Month And To Logmar 0.42 +/- 0.23 At Three Months (P < 0.05). The Mean Central Macular Thickness Decreased From 429.5 +/- 71.9 microM At Baseline To 299.9 +/- 81.2 microM At One Month And To 284.6 +/- 82.6 microM At Three Months (P < 0.05). No Adverse Side Effects Were Observed Following the injections. CONCLUSIONS: The observed macular edema and visual acuity improvements demonstrated that intravitreal ranibizumab injection may be useful for the treatment of patients with diabetic macular edema. |
| Key Words:
Diabetic macular edema;Ranibizumab |
PDF Links
Full text via DOI
Download Citation
